David M. Mintzer

3.1k total citations
60 papers, 2.3k citations indexed

About

David M. Mintzer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David M. Mintzer has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David M. Mintzer's work include Occupational and environmental lung diseases (14 papers), Lung Cancer Treatments and Mutations (9 papers) and Pleural and Pulmonary Diseases (9 papers). David M. Mintzer is often cited by papers focused on Occupational and environmental lung diseases (14 papers), Lung Cancer Treatments and Mutations (9 papers) and Pleural and Pulmonary Diseases (9 papers). David M. Mintzer collaborates with scholars based in United States and Israel. David M. Mintzer's co-authors include Carlos Cordon‐Cardo, E A Carswell, Herbert F. Oettgen, Alan N. Houghton, Malcolm Maclure, Jane B. Sherwood, Murray A. Mittleman, Geoffrey H. Tofler, James E. Muller and L J Old and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

David M. Mintzer

60 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Mintzer United States	22	545	477	441	439	402	60	2.3k
Hideto Kameda Japan	38	398 0.7×	480 1.0×	266 0.6×	411 0.9×	1.2k 2.9×	196	4.3k
Elliot Chartash United States	23	792 1.5×	285 0.6×	566 1.3×	348 0.8×	1.4k 3.5×	49	4.7k
Nelson Hamerschlak Brazil	25	588 1.1×	433 0.9×	170 0.4×	446 1.0×	301 0.7×	269	3.2k
Stein Kvaløy Norway	31	1.5k 2.7×	437 0.9×	235 0.5×	161 0.4×	370 0.9×	94	3.2k
Serge Uzan France	42	891 1.6×	409 0.9×	314 0.7×	336 0.8×	442 1.1×	118	5.3k
Dae‐Hyun Yoo South Korea	35	360 0.7×	173 0.4×	464 1.1×	618 1.4×	2.8k 7.1×	198	5.3k
Elena Massarotti United States	22	223 0.4×	117 0.2×	252 0.6×	608 1.4×	790 2.0×	38	2.6k
Rüdiger P. Laubender Germany	29	803 1.5×	330 0.7×	178 0.4×	355 0.8×	358 0.9×	60	2.3k
Henry C. Fung United States	25	790 1.4×	182 0.4×	131 0.3×	309 0.7×	302 0.8×	99	2.1k
Alfred Ian Lee United States	18	407 0.7×	116 0.2×	147 0.3×	483 1.1×	469 1.2×	100	2.0k

Countries citing papers authored by David M. Mintzer

Since Specialization

Citations

This map shows the geographic impact of David M. Mintzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Mintzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Mintzer more than expected).

Fields of papers citing papers by David M. Mintzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Mintzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Mintzer. The network helps show where David M. Mintzer may publish in the future.

Co-authorship network of co-authors of David M. Mintzer

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Mintzer. A scholar is included among the top collaborators of David M. Mintzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Mintzer. David M. Mintzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mintzer, David M., et al.. (2019). Benzodiazepines vs barbiturates for alcohol withdrawal: Analysis of 3 different treatment protocols. The American Journal of Emergency Medicine. 37(4). 733–736. 30 indexed citations

Granda-Cameron, Clara, et al.. (2015). Risk Factors Associated With Unplanned Hospital Readmissions in Adults With Cancer. Oncology nursing forum. 42(3). E257–E268. 18 indexed citations

Dotan, Efrat, Neal J. Meropol, Barbara Burtness, et al.. (2012). A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study. Journal of Gastrointestinal Cancer. 43(4). 562–569. 24 indexed citations

Schwartzberg, Lee S., et al.. (2011). Phase II Multicenter Trial of Albumin-Bound Paclitaxel and Capecitabine in First-Line Treatment of Patients With Metastatic Breast Cancer. Clinical Breast Cancer. 12(2). 87–93. 24 indexed citations

Granda-Cameron, Clara, et al.. (2010). An Interdisciplinary Approach to Manage Cancer Cachexia. Clinical journal of oncology nursing. 14(1). 72–80. 36 indexed citations

Huang, Chao, Michael Millenson, Eric J. Sherman, et al.. (2008). Promising Survival in Patients with Recurrent Non-small Cell Lung Cancer Treated with Docetaxel and Gemcitabine in Combination as Second-Line Therapy. Journal of Thoracic Oncology. 3(9). 1032–1038. 5 indexed citations

Borghaei, Hossein, Corey J. Langer, Michael Millenson, et al.. (2008). Phase II Study of Paclitaxel, Carboplatin, and Cetuximab as First Line Treatment, for Patients with Advanced Non-small Cell Lung Cancer (NSCLC): Results of OPN-017. Journal of Thoracic Oncology. 3(11). 1286–1292. 42 indexed citations

Granda-Cameron, Clara, et al.. (2007). Bringing an Inpatient Palliative Care Program to a Teaching Hospital: Lessons in Leadership. Oncology nursing forum. 34(4). 772–776. 1 indexed citations

Mintzer, David M., et al.. (2007). Treating One of Our Own. Clinical journal of oncology nursing. 11(2). 227–231. 3 indexed citations

10.

Langer, Corey J., Karen Ruth, Hossein Borghaei, et al.. (2007). PD3-2-8: Phase II Trial of Cetuximab (C225) in Combination with Monthly Carboplatin (Cb) and Weekly Paclitaxel (Pac) in Patients with Advanced NSCLC: Promising Early Results. Journal of Thoracic Oncology. 2(8). S465–S466. 1 indexed citations

11.

Jänne, Pasi A., Antoinette J. Wozniak, Chandra P. Belani, et al.. (2006). Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program. Journal of Thoracic Oncology. 1(6). 506–512. 50 indexed citations

12.

Treat, Joseph, Philip Bonomi, Michael McCleod, et al.. (2006). Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: A phase II trial. Lung Cancer. 53(1). 77–83. 17 indexed citations

13.

Jänne, Pasi A., Antoinette J. Wozniak, Chandra P. Belani, et al.. (2005). Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program. Clinical Lung Cancer. 7(1). 40–46. 143 indexed citations

14.

Davis, Amy, et al.. (2005). Chemotherapy-Induced Amenorrhea from Adjuvant Breast Cancer Treatment: The Effect of the Addition of Taxanes. Clinical Breast Cancer. 6(5). 421–424. 48 indexed citations

15.

Mintzer, David M. & Bernard A. Mason. (2003). On the Need for Biopsy Confirmation at Suspected First Recurrence of Cancer. American Journal of Clinical Oncology. 26(2). 192–196. 2 indexed citations

16.

Mintzer, David M. & Adam Bagg. (2001). Clinical syndromes of transformation in clonal hematologic disorders. The American Journal of Medicine. 111(6). 480–488. 3 indexed citations

17.

Vaughn, David J., N J Meropol, Christopher P. Holroyde, et al.. (1997). A Phase II Study of 5-Fluorouracil, Leucovorin, Adriamycin, and Cisplatin (FLAP) for Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma. American Journal of Clinical Oncology. 20(3). 242–246. 6 indexed citations

18.

Hofmann, J., David M. Mintzer, & Michael J. Warhol. (1994). Malignant mesothelioma following radiation therapy. The American Journal of Medicine. 97(4). 379–382. 28 indexed citations

19.

Mintzer, David M., et al.. (1992). Digital gangrene following chemotherapy for aids-related Kaposi's sarcoma. The American Journal of Medicine. 93(5). 581–582. 10 indexed citations

20.

Mintzer, David M., et al.. (1988). Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency syndrome. The American Journal of Medicine. 85(3). 445–445. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact